期刊
BIOORGANIC & MEDICINAL CHEMISTRY
卷 24, 期 5, 页码 1132-1135出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2016.01.044
关键词
Glycopeptides; Nanoparticles; Vaccines; Antibodies; Cancer
资金
- Alexander von Humboldt Fellowship
- Research Center for Immunotherapy (FZI) of the University Medical Center of JGU Mainz [SFB 1066]
We report the preparation of gold nanoparticle (AuNP)-based vaccine candidates against the tumor-associated form of the mucin-1 (MUC1) glycoprotein. Chimeric peptides, consisting of a glycopeptide sequence derived from MUC1 and the T-cell epitope P30 sequence were immobilized on PEGylated AuNPs and the ability to induce selective antibodies in vivo was investigated. After immunization, mice showed significant MHC-II mediated immune responses and their antisera recognized human MCF-7 breast cancer cells. Nanoparticles designed according to this report may become key players in the development of anticancer vaccines. (C) 2016 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据